Menu

RWEpi
Real World Epidemiology Research Group (RWEpi)

Group leader
avatar_investigadors.jpg
Talita Duarte Salles
avatar_grups_recerca.png

Projects

Group projects

Incidence, prevalence, and characterisation of medicines with suggested drug shortages in Europe

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00227-23
  • Start year: 2024

Characterization of incidental and chronic use of macrolides in patients with asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap syndrome (ACOS); a pharmacoepidemiologic drug utilization study with data mapped to the Observational Medical Outcomes Partnership – Common Data Model (OMOP-CDM)

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00001-24
  • Start year: 2024
  • Funders: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC)

DARWIN EU® – Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00018-24
  • Start year: 2024
  • Funders: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC)

DARWIN EU® – Frailty and polypharmacy among adults aged 18 and above with cancer at the time of diagnosis

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00026-24
  • Start year: 2024
  • Funders: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC)

DARWIN EU® – Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00031-24
  • Start year: 2024
  • Funders: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC)

Board of Trustees

Collaborators

Accreditations